A recent preprint introduces TumorLens, a long-read framework for unified cancer profiling, detecting genetic and epigenetic alterations in a single assay, from SNVs to methylation.
Uncover the science behind it: www.medrxiv.org/content/10.6...
Accurately resolving the full spectrum of somatic alterations remains a major barrier in cancer genomics. Current short-read sequencing methods often prioritize SNVs and copy-number changes while over...
